Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
life sciences
national blog main
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
5
×
fda
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
drugs
indiana blog main
indiana top stories
pfizer
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
akcea therapeutics
biotech
cancer
inotersen
merck
national
onpattro
patisiran
tafamidis
4d molecular therapeutics
abbvie
What
approved
5
×
drug
5
×
fda
5
×
alnylam
disease
genetic
medicine
oks
time
afternoon
agency
ago
aimmune
akcea
allergy
alnylam’s
amyloidosis
approval
attr
available
awarded
battle
bio
cancer
companies
debilitating
deeper
developed
digital
dna
epidemic
fatty
fingerprint
frenzied
friday
gets
going
growing
history
immunotherapy
Language
unset
Current search:
drug
×
approved
×
" san diego top stories "
×
fda
×
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
6 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug